These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30885275)

  • 1. Probabilistic independent component analysis of dynamic susceptibility contrast perfusion MRI in metastatic brain tumors.
    Chakhoyan A; Raymond C; Chen J; Goldman J; Yao J; Kaprealian TB; Pouratian N; Ellingson BM
    Cancer Imaging; 2019 Mar; 19(1):14. PubMed ID: 30885275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
    Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
    Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
    Muto M; Frauenfelder G; Senese R; Zeccolini F; Schena E; Giurazza F; Jäger HR
    Radiol Med; 2018 Jul; 123(7):545-552. PubMed ID: 29508242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of Hemangioblastoma from Metastatic Brain Tumor using Dynamic Contrast-enhanced MR Imaging.
    Cha J; Kim ST; Nam DH; Kong DS; Kim HJ; Kim YK; Kim HY; Park GM; Jeon P; Kim KH; Byun HS
    Clin Neuroradiol; 2017 Sep; 27(3):329-334. PubMed ID: 26952018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain abscess and cystic brain tumor: discrimination with dynamic susceptibility contrast perfusion-weighted MRI.
    Erdogan C; Hakyemez B; Yildirim N; Parlak M
    J Comput Assist Tomogr; 2005; 29(5):663-7. PubMed ID: 16163039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.
    Kong Z; Yan C; Zhu R; Wang J; Wang Y; Wang Y; Wang R; Feng F; Ma W
    Neuroimage Clin; 2018; 20():51-60. PubMed ID: 30069427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H; Steffensen E; Larsson EM
    Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic generation of DSC-MRI-derived relative CBV maps from DCE MRI of brain tumors.
    Sanders JW; Chen HS; Johnson JM; Schomer DF; Jimenez JE; Ma J; Liu HL
    Magn Reson Med; 2021 Jan; 85(1):469-479. PubMed ID: 32726488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
    Burth S; Kickingereder P; Eidel O; Tichy D; Bonekamp D; Weberling L; Wick A; Löw S; Hertenstein A; Nowosielski M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
    Neuro Oncol; 2016 Dec; 18(12):1673-1679. PubMed ID: 27298312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of brain infection from necrotic glioblastoma using combined analysis of diffusion and perfusion MRI.
    Chawla S; Wang S; Mohan S; Nasrallah M; Verma G; Brem S; O'Rourke DM; Wolf RL; Poptani H; Nabavizadeh SA
    J Magn Reson Imaging; 2019 Jan; 49(1):184-194. PubMed ID: 29676844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion and perfusion MR patterns of central nervous system lymphomas.
    Neska-Matuszewska M; Zimny A; Bladowska J; Sąsiadek M
    Adv Clin Exp Med; 2018 Aug; 27(8):1099-1108. PubMed ID: 29975467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.
    Neska-Matuszewska M; Bladowska J; Sąsiadek M; Zimny A
    PLoS One; 2018; 13(1):e0191341. PubMed ID: 29342201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of Glioblastoma and Solitary Brain Metastasis by Gradient of Relative Cerebral Blood Volume in the Peritumoral Brain Zone Derived from Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging.
    She D; Xing Z; Cao D
    J Comput Assist Tomogr; 2019; 43(1):13-17. PubMed ID: 30015801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DCE and DSC perfusion MRI diagnostic accuracy in the follow-up of primary and metastatic intra-axial brain tumors treated by radiosurgery with cyberknife.
    Morabito R; Alafaci C; Pergolizzi S; Pontoriero A; Iati' G; Bonanno L; Gaeta M; Salpietro FM; Mormina E; Longo M; Granata F
    Radiat Oncol; 2019 Apr; 14(1):65. PubMed ID: 30992043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner.
    Sentürk S; Oğuz KK; Cila A
    Diagn Interv Radiol; 2009 Mar; 15(1):3-12. PubMed ID: 19263367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.
    Askaner K; Rydelius A; Engelholm S; Knutsson L; Lätt J; Abul-Kasim K; Sundgren PC
    J Neuroradiol; 2019 Nov; 46(6):367-372. PubMed ID: 30389510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfusion MR imaging of enhancing brain tumors: Comparison of arterial spin labeling technique with dynamic susceptibility contrast technique.
    Soni N; Dhanota DPS; Kumar S; Jaiswal AK; Srivastava AK
    Neurol India; 2017; 65(5):1046-1052. PubMed ID: 28879895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of choline levels and tumor perfusion in brain metastases assessed with proton MR spectroscopy and dynamic susceptibility contrast-enhanced perfusion weighted MRI.
    Huang BY; Kwock L; Castillo M; Smith JK
    Technol Cancer Res Treat; 2010 Aug; 9(4):327-37. PubMed ID: 20626199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of pilocytic and pilomyxoid astrocytomas using dynamic susceptibility contrast perfusion and diffusion weighted imaging.
    Ho CY; Supakul N; Patel PU; Seit V; Groswald M; Cardinal J; Lin C; Kralik SF
    Neuroradiology; 2020 Jan; 62(1):81-88. PubMed ID: 31676961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of survival in patients affected by glioblastoma: histogram analysis of perfusion MRI.
    Romano A; Pasquini L; Di Napoli A; Tavanti F; Boellis A; Rossi Espagnet MC; Minniti G; Bozzao A
    J Neurooncol; 2018 Sep; 139(2):455-460. PubMed ID: 29721752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.